ID   V1AR_RAT                Reviewed;         424 AA.
AC   P30560; Q5M8D1; Q62874; Q9QW18;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 4.
DT   07-APR-2021, entry version 164.
DE   RecName: Full=Vasopressin V1a receptor;
DE            Short=V1aR;
DE   AltName: Full=AVPR V1a;
DE   AltName: Full=Antidiuretic hormone receptor 1a;
DE   AltName: Full=Vascular/hepatic-type arginine vasopressin receptor;
GN   Name=Avpr1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1560825; DOI=10.1038/356523a0;
RA   Morel A., O'Carroll A.-M., Brownstein M.J., Lolait S.J.;
RT   "Molecular cloning and expression of a rat V1a arginine vasopressin
RT   receptor.";
RL   Nature 356:523-526(1992).
RN   [2]
RP   SEQUENCE REVISION TO 112-117.
RX   PubMed=8257445; DOI=10.1042/bj2960519;
RA   Wheatley M., Howl J., Morel A., Davis A.R.L.;
RT   "Homology between neurohypophyseal hormone receptors.";
RL   Biochem. J. 296:519-519(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=8670090;
RA   Innamorati G., Lolait S.J., Birnbaumer M.;
RT   "Sequence identity between the rat and human vasopressin V1a receptors.";
RL   Biochem. J. 314:710-711(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-395.
RX   PubMed=8511367; DOI=10.1016/0167-0115(93)90182-8;
RA   Morel A., Lolait S.J., Brownstein M.J.;
RT   "Molecular cloning and expression of rat V1a and V2 arginine vasopressin
RT   receptors.";
RL   Regul. Pept. 45:53-59(1993).
RN   [6]
RP   MUTAGENESIS OF TYR-115.
RX   PubMed=7774575; DOI=10.1002/j.1460-2075.1995.tb07211.x;
RA   Chini B., Mouillac B., Ala Y., Balestre M.-N., Trumpp-Kallmeyer S.,
RA   Hoflack J., Elands J., Hibert M., Manning M., Jard S., Barberis C.;
RT   "Tyr115 is the key residue for determining agonist selectivity in the V1a
RT   vasopressin receptor.";
RL   EMBO J. 14:2176-2182(1995).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=9105680; DOI=10.1016/s0169-328x(96)00285-9;
RA   Yamazaki R.S., Chen Q., Schreiber S.S., Brinton R.D.;
RT   "Localization of V1a vasopressin receptor mRNA expression in cultured
RT   neurons, astroglia, and oligodendroglia of rat cerebral cortex.";
RL   Brain Res. Mol. Brain Res. 45:138-140(1997).
RN   [8]
RP   MUTAGENESIS OF ASN-14 AND ASN-27, AND SUBCELLULAR LOCATION.
RX   PubMed=11520055; DOI=10.1006/bbrc.2001.5456;
RA   Lee K.-H., Ahn J., Yu D.-H., Jeong H.-S., Lee S.-H., Kim K.-S.,
RA   Chung I.-Y., Kim J.-H., Lee Y.-S.;
RT   "Effect of N-glycosylation on ligand binding affinity of rat V1a
RT   vasopressin receptor.";
RL   Biochem. Biophys. Res. Commun. 286:707-713(2001).
RN   [9]
RP   PALMITOYLATION AT CYS-371 AND CYS-372, AND MUTAGENESIS OF CYS-371 AND
RP   CYS-372.
RX   PubMed=11466323; DOI=10.1074/jbc.m106142200;
RA   Hawtin S.R., Tobin A.B., Patel S., Wheatley M.;
RT   "Palmitoylation of the vasopressin V1a receptor reveals different
RT   conformational requirements for signaling, agonist-induced receptor
RT   phosphorylation, and sequestration.";
RL   J. Biol. Chem. 276:38139-38146(2001).
RN   [10]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12399435; DOI=10.1210/en.2002-220603;
RA   Orcel H., Tobin V.A., Alonso G., Rabie A.;
RT   "Immunocytochemical localization of vasopressin v1a receptors in the rat
RT   pituitary gonadotropes.";
RL   Endocrinology 143:4385-4388(2002).
RN   [11]
RP   ROLE IN SOCIAL BEHAVIOR.
RX   PubMed=12887422; DOI=10.1046/j.1460-9568.2003.02750.x;
RA   Landgraf R., Frank E., Aldag J.M., Neumann I.D., Sharer C.A., Ren X.,
RA   Terwilliger E.F., Niwa M., Wigger A., Young L.J.;
RT   "Viral vector-mediated gene transfer of the vole V1a vasopressin receptor
RT   in the rat septum: improved social discrimination and active social
RT   behaviour.";
RL   Eur. J. Neurosci. 18:403-411(2003).
CC   -!- FUNCTION: Receptor for arginine vasopressin. The activity of this
CC       receptor is mediated by G proteins which activate a phosphatidyl-
CC       inositol-calcium second messenger system. Involved in social memory
CC       formation. {ECO:0000269|PubMed:12887422}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cytoplasmic vesicle membrane; Multi-pass membrane protein. Note=Located
CC       in cytoplasmic vesicles dispersed throughout the cell cytoplasm and to
CC       the plasma membrane.
CC   -!- TISSUE SPECIFICITY: Localized within gonadotropes of the anterior
CC       pituitary of the brain. Broadly distributed throughout the cerebral
CC       cortex. {ECO:0000269|PubMed:12399435, ECO:0000269|PubMed:9105680}.
CC   -!- PTM: Palmitoylated on three cysteine residues, of which only two are
CC       identified. {ECO:0000269|PubMed:11466323}.
CC   -!- MISCELLANEOUS: Overexpression of AVPR1A in the brain increases the
CC       duration of social memory.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Vasopressin/oxytocin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00521}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA77748.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z11690; CAA77748.1; ALT_INIT; mRNA.
DR   EMBL; U39450; AAC52507.1; -; Genomic_DNA.
DR   EMBL; BC088095; AAH88095.1; -; Genomic_DNA.
DR   PIR; S71837; S71837.
DR   RefSeq; NP_444178.2; NM_053019.2.
DR   IntAct; P30560; 2.
DR   STRING; 10116.ENSRNOP00000005829; -.
DR   BindingDB; P30560; -.
DR   ChEMBL; CHEMBL2868; -.
DR   DrugCentral; P30560; -.
DR   GuidetoPHARMACOLOGY; 366; -.
DR   GlyGen; P30560; 1 site.
DR   PhosphoSitePlus; P30560; -.
DR   SwissPalm; P30560; -.
DR   PaxDb; P30560; -.
DR   PRIDE; P30560; -.
DR   Ensembl; ENSRNOT00000005829; ENSRNOP00000005829; ENSRNOG00000004400.
DR   GeneID; 25107; -.
DR   KEGG; rno:25107; -.
DR   CTD; 552; -.
DR   RGD; 2185; Avpr1a.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01020000230440; -.
DR   InParanoid; P30560; -.
DR   OMA; RFRGPDW; -.
DR   OrthoDB; 890925at2759; -.
DR   PhylomeDB; P30560; -.
DR   TreeFam; TF106499; -.
DR   Reactome; R-RNO-388479; Vasopressin-like receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   PRO; PR:P30560; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004400; Expressed in liver and 21 other tissues.
DR   ExpressionAtlas; P30560; baseline and differential.
DR   Genevisible; P30560; RN.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:RGD.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030139; C:endocytic vesicle; ISO:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0042277; F:peptide binding; IBA:GO_Central.
DR   GO; GO:0017046; F:peptide hormone binding; IMP:RGD.
DR   GO; GO:0031894; F:V1A vasopressin receptor binding; IDA:UniProtKB.
DR   GO; GO:0005000; F:vasopressin receptor activity; IDA:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:RGD.
DR   GO; GO:0042631; P:cellular response to water deprivation; IEP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007625; P:grooming behavior; IMP:RGD.
DR   GO; GO:0002125; P:maternal aggressive behavior; IMP:RGD.
DR   GO; GO:0042711; P:maternal behavior; IMP:RGD.
DR   GO; GO:0014902; P:myotube differentiation; IEP:RGD.
DR   GO; GO:0007621; P:negative regulation of female receptivity; IMP:RGD.
DR   GO; GO:0051970; P:negative regulation of transmission of nerve impulse; IMP:RGD.
DR   GO; GO:0043084; P:penile erection; IMP:RGD.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IMP:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0032849; P:positive regulation of cellular pH reduction; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IMP:RGD.
DR   GO; GO:0045819; P:positive regulation of glycogen catabolic process; NAS:UniProtKB.
DR   GO; GO:0010460; P:positive regulation of heart rate; IMP:RGD.
DR   GO; GO:0031394; P:positive regulation of prostaglandin biosynthetic process; IMP:RGD.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; IMP:RGD.
DR   GO; GO:0003084; P:positive regulation of systemic arterial blood pressure; IMP:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; NAS:UniProtKB.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0051459; P:regulation of corticotropin secretion; NAS:UniProtKB.
DR   GO; GO:0001992; P:regulation of systemic arterial blood pressure by vasopressin; ISO:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IEP:RGD.
DR   GO; GO:0010035; P:response to inorganic substance; IMP:RGD.
DR   GO; GO:0010033; P:response to organic substance; IMP:RGD.
DR   GO; GO:0035176; P:social behavior; IDA:UniProtKB.
DR   GO; GO:0042713; P:sperm ejaculation; IMP:RGD.
DR   GO; GO:0021537; P:telencephalon development; IEP:RGD.
DR   InterPro; IPR015076; DUF1856.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001817; Vasoprsn_rcpt.
DR   InterPro; IPR001224; Vprs_V1A_rcpt.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF08983; DUF1856; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00896; VASOPRESSINR.
DR   PRINTS; PR00752; VASOPRSNV1AR.
DR   SMART; SM01164; DUF1856; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cytoplasmic vesicle; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..424
FT                   /note="Vasopressin V1a receptor"
FT                   /id="PRO_0000070201"
FT   TOPO_DOM        1..52
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        53..76
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        77..88
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        89..110
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        111..125
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        126..147
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        148..168
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        169..190
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        191..220
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        221..241
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        242..299
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        300..319
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        320..337
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        338..357
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        358..424
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62463"
FT   LIPID           371
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:11466323"
FT   LIPID           372
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:11466323"
FT   CARBOHYD        27
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        124..205
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   MUTAGEN         14
FT                   /note="N->Q: Reduced ligand binding affinity."
FT                   /evidence="ECO:0000269|PubMed:11520055"
FT   MUTAGEN         27
FT                   /note="N->Q: Reduced ligand binding affinity."
FT                   /evidence="ECO:0000269|PubMed:11520055"
FT   MUTAGEN         115
FT                   /note="Y->D: No significant change in affinity for arginine
FT                   vasopressin or oxytocin. Increased affinity for 1-deamino,
FT                   D-Arg8-vasopressin."
FT                   /evidence="ECO:0000269|PubMed:7774575"
FT   MUTAGEN         115
FT                   /note="Y->F: 17-fold increase in affinity for oxytocin. No
FT                   change in affinity for arginine vasopressin or 1-deamino,
FT                   D-Arg8-vasopressin."
FT                   /evidence="ECO:0000269|PubMed:7774575"
FT   MUTAGEN         115
FT                   /note="Y->L: 50-fold decrease in affinity for arginine
FT                   vasopressin. Little affect on affinity for oxytocin or 1-
FT                   deamino, D-Arg8-vasopressin."
FT                   /evidence="ECO:0000269|PubMed:7774575"
FT   MUTAGEN         371
FT                   /note="C->G: Reduced palmitoylation, coupling to G protein
FT                   unaffected. Abolished isoprenylation, coupling to G protein
FT                   unaffected; when associated with G-372."
FT                   /evidence="ECO:0000269|PubMed:11466323"
FT   MUTAGEN         372
FT                   /note="C->G: Reduced palmitoylation, coupling to G protein
FT                   unaffected. Abolished isoprenylation, coupling to G protein
FT                   unaffected; when associated with G-371."
FT                   /evidence="ECO:0000269|PubMed:11466323"
FT   CONFLICT        115..116
FT                   /note="YR -> SS (in Ref. 3 and 5)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        390..424
FT                   /note="RQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST -> KTDFLF (in
FT                   Ref. 1; CAA77748)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   424 AA;  47655 MW;  4F452C8DF7B4C900 CRC64;
     MSFPRGSQDR SVGNSSPWWP LTTEGSNGSQ EAARLGEGDS PLGDVRNEEL AKLEIAVLAV
     IFVVAVLGNS SVLLALHRTP RKTSRMHLFI RHLSLADLAV AFFQVLPQLC WDITYRFRGP
     DWLCRVVKHL QVFAMFASAY MLVVMTADRY IAVCHPLKTL QQPARRSRLM IATSWVLSFI
     LSTPQYFIFS VIEIEVNNGT KTQDCWATFI QPWGTRAYVT WMTSGVFVAP VVVLGTCYGF
     ICYHIWRNIR GKTASSRHSK GDKGSGEAVG PFHKGLLVTP CVSSVKSISR AKIRTVKMTF
     VIVSAYILCW APFFIVQMWS VWDENFIWTD SENPSITITA LLASLNSCCN PWIYMFFSGH
     LLQDCVQSFP CCHSMAQKFA KDDSDSMSRR QTSYSNNRSP TNSTGMWKDS PKSSKSIRFI
     PVST
//
